title: [Recommendations on the therapy of bronchial carcinoma].
authors.affiliation: Klinik für Hämatologie, Onkologie und Pneumologie, Medizinische Klinik A, Universitätsklinikum Münster, Germany. mthomas@uni-muenster.de
authors.forename: M
authors.initials: M
authors.lastname: Thomas
authors.forename: M
authors.initials: M
authors.lastname: Baumann
authors.forename: M
authors.initials: M
authors.lastname: Deppermann
authors.forename: L
authors.initials: L
authors.lastname: Freitag
authors.forename: U
authors.initials: U
authors.lastname: Gatzemeier
authors.forename: R
authors.initials: R
authors.lastname: Huber
authors.forename: B
authors.initials: B
authors.lastname: Passlick
authors.forename: M
authors.initials: M
authors.lastname: Serke
authors.forename: D
authors.initials: D
authors.lastname: Ukena
mesh_terms: D002283:Carcinoma, Bronchogenic / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D018288:Carcinoma, Small Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D019091:Critical Pathways; D005858:Germany; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D010166:Palliative Care; D017410:Practice Guidelines as Topic; D015996:Survival Rate